Corcept Therapeutics Shares Outstanding 2006-2020 | CORT

Corcept Therapeutics shares outstanding from 2006 to 2020. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Corcept Therapeutics Annual Shares Outstanding
(Millions of Shares)
2019 123
2018 127
2017 125
2016 116
2015 107
2014 101
2013 100
2012 93
2011 83
2010 68
2009 52
2008 47
2007 34
2006 23
2005 23
Corcept Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
2020-09-30 124
2020-06-30 123
2020-03-31 122
2019-12-31 123
2019-09-30 122
2019-06-30 122
2019-03-31 124
2018-12-31 127
2018-09-30 126
2018-06-30 128
2018-03-31 128
2017-12-31 125
2017-09-30 126
2017-06-30 123
2017-03-31 121
2016-12-31 116
2016-09-30 116
2016-06-30 115
2016-03-31 110
2015-12-31 107
2015-09-30 108
2015-06-30 108
2015-03-31 102
2014-12-31 101
2014-09-30 101
2014-06-30 101
2014-03-31 101
2013-12-31 100
2013-09-30 100
2013-06-30 100
2013-03-31 100
2012-12-31 93
2012-09-30 99
2012-06-30 89
2012-03-31 84
2011-12-31 83
2011-09-30 84
2011-06-30 84
2011-03-31 81
2010-12-31 68
2010-09-30 72
2010-06-30 66
2010-03-31 63
2009-12-31 52
2009-09-30 50
2009-06-30 50
2009-03-31 50
2008-12-31 47
2008-09-30 49
2008-06-30 48
2008-03-31 40
2007-12-31 34
2007-09-30 37
2007-06-30 35
2007-03-31 26
2006-12-31 23
2006-09-30 23
2006-06-30 23
2006-03-31 23
2005-12-31 23
2005-09-30 23
2005-06-30 23
2005-03-31 23
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.269B $0.306B
Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol. It is developing its lead product, CORLUX for the treatment of the psychotic features of psychotic major depression. Corcept Therapeutics Incorporated is headquartered in Menlo Park, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.784B 41.85
Takeda Pharmaceutical (TAK) Japan $54.984B 10.26
Astellas Pharma (ALPMY) Japan $29.565B 18.47
Merck (MKGAF) Germany $22.940B 0.00
Eisai (ESALY) Japan $22.210B 19.35
UCB SA (UCBJF) Belgium $20.583B 0.00
Catalent (CTLT) United States $19.023B 56.90
Grifols, S.A (GRFS) Spain $13.118B 15.02
Neurocrine Biosciences (NBIX) United States $10.061B 79.18
Jazz Pharmaceuticals (JAZZ) Ireland $9.344B 15.10
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.578B 0.00
Ionis Pharmaceuticals (IONS) United States $8.568B 83.94
Arrowhead Pharmaceuticals (ARWR) United States $8.297B 0.00
United Therapeutics (UTHR) United States $7.680B 16.35
IPSEN SA ADR (IPSEY) France $7.218B 0.00
STADA ARZNEIMI (STDAF) Germany $6.884B 0.00
Orion OYJ (ORINY) Finland $6.427B 22.30
Evotec AG (EVTCY) Germany $5.819B 394.44
Sage Therapeutics (SAGE) United States $4.756B 0.00
PTC Therapeutics (PTCT) United States $4.673B 0.00
Hypermarcas (HYPMY) Brazil $4.415B 17.42
ChemoCentryx (CCXI) United States $4.292B 0.00
FibroGen (FGEN) United States $3.934B 0.00
Cronos Group (CRON) Canada $3.889B 0.00
Pacira BioSciences (PCRX) United States $3.201B 69.51
Nektar Therapeutics (NKTR) United States $3.046B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.972B 15.17
Xencor (XNCR) United States $2.784B 0.00
Revolution Medicines (RVMD) United States $2.706B 0.00
Tilray (TLRY) Canada $2.630B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.766B 15.11
Translate Bio (TBIO) United States $1.734B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.685B 0.00
USANA Health Sciences (USNA) United States $1.669B 14.69
Endo (ENDP) Ireland $1.640B 2.49
Heron Therapeutics (HRTX) United States $1.603B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.554B 0.00
Ocular Therapeutix (OCUL) United States $1.542B 0.00
Trillium Therapeutics (TRIL) Canada $1.470B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.448B 10.06
ImmunoGen (IMGN) United States $1.404B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.151B 0.00
Indivior (INVVY) United States $1.139B 0.00
Karyopharm Therapeutics (KPTI) United States $1.100B 0.00
Zogenix (ZGNX) United States $1.038B 0.00
ORGANOGENESIS (ORGO) United States $1.024B 0.00
Radius Health (RDUS) United States $1.012B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.942B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.938B 0.00
Vectura Group (VEGPF) United Kingdom $0.925B 0.00
Collegium Pharmaceutical (COLL) United States $0.832B 49.10
VAXART, INC (VXRT) United States $0.786B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.721B 0.00
Esperion Therapeutics (ESPR) United States $0.712B 0.00
Acutus Medical (AFIB) United States $0.659B 0.00
Aerie Pharmaceuticals (AERI) United States $0.653B 0.00
Flexion Therapeutics (FLXN) United States $0.644B 0.00
Chinook Therapeutics (KDNY) United States $0.641B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.635B 0.00
Ardelyx (ARDX) United States $0.615B 0.00
Harpoon Therapeutics (HARP) United States $0.594B 0.00
Siga Technologies (SIGA) United States $0.563B 15.80
Molecular Templates (MTEM) United States $0.552B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.524B 0.00
Sundial Growers (SNDL) Canada $0.504B 0.00
PROFOUND MEDICL (PROF) Canada $0.491B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.468B 0.00
Akebia Therapeutics (AKBA) United States $0.441B 0.00
Summit Therapeutics (SMMT) United States $0.438B 0.00
Altimmune (ALT) United States $0.428B 0.00
CASI Pharmaceuticals (CASI) United States $0.420B 0.00
TherapeuticsMD (TXMD) United States $0.414B 0.00
DURECT (DRRX) United States $0.412B 0.00
Rafael Holdings (RFL) United States $0.400B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.389B 0.00
Innate Pharma SA (IPHYF) France $0.371B 0.00
Jounce Therapeutics (JNCE) United States $0.363B 0.00
Concert Pharmaceuticals (CNCE) United States $0.363B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.362B 9.43
Matinas Biopharma Holdings (MTNB) United States $0.327B 0.00
MEI Pharma (MEIP) United States $0.320B 0.00
Alpine Immune Sciences (ALPN) United States $0.313B 0.00
KalVista Pharmaceuticals (KALV) United States $0.312B 0.00
Nature's Sunshine Products (NATR) United States $0.304B 19.59
Menlo Therapeutics (VYNE) United States $0.280B 0.00
Lannett Co Inc (LCI) United States $0.279B 7.36
Redhill Biopharma (RDHL) Israel $0.278B 0.00
Jaguar Animal Health (JAGX) United States $0.266B 0.00
Xeris Pharmaceuticals (XERS) United States $0.263B 0.00
Aclaris Therapeutics (ACRS) United States $0.252B 0.00
Otonomy (OTIC) United States $0.251B 0.00
CTI BioPharma (CTIC) United States $0.245B 0.00
IMV INC (IMV) Canada $0.237B 0.00
Calithera Biosciences (CALA) United States $0.235B 0.00
OptiNose (OPTN) United States $0.218B 0.00
Oncternal Therapeutics (ONCT) United States $0.213B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.209B 0.00
Infinity Pharmaceuticals (INFI) United States $0.204B 0.00
ProPhase Labs (PRPH) United States $0.194B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.188B 0.00
Novan (NOVN) United States $0.180B 0.00
Aquestive Therapeutics (AQST) United States $0.179B 0.00
IsoRay (ISR) United States $0.173B 0.00
Onconova Therapeutics (ONTX) United States $0.172B 0.00
Taiwan Liposome (TLC) Taiwan $0.166B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.166B 0.00
Ayala Pharmaceuticals (AYLA) Israel $0.165B 0.00
Champions Oncology (CSBR) United States $0.150B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.146B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.146B 0.00
Heat Biologics (HTBX) United States $0.145B 0.00
MediWound (MDWD) Israel $0.137B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.113B 0.00
Lipocine (LPCN) United States $0.106B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.099B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.094B 0.00
SCYNEXIS (SCYX) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.083B 0.00
Natural Alternatives (NAII) United States $0.082B 158.75
ElectroCore (ECOR) United States $0.080B 0.00
Nutriband (NTRB) United States $0.077B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.076B 0.00
Recro Pharma (REPH) United States $0.070B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.070B 0.00
AgeX Therapeutics (AGE) United States $0.069B 0.00
Biomerica (BMRA) United States $0.067B 0.00
India Globalization Capital (IGC) United States $0.065B 0.00
CV Sciences (CVSI) United States $0.064B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.063B 0.00
Iterum Therapeutics (ITRM) Ireland $0.059B 0.00
Vical (BBI) United States $0.059B 0.00
Addex Therapeutics (ADXN) Switzerland $0.059B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.054B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.049B 24.96
Regulus Therapeutics (RGLS) United States $0.047B 0.00
PolarityTE (PTE) United States $0.042B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.038B 0.00
Mannatechorporated (MTEX) United States $0.038B 5.56
Opiant Pharmaceuticals (OPNT) United States $0.037B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.029B 0.00
Flex Pharma (SLRX) United States $0.029B 0.00
Midatech Pharma (MTP) United Kingdom $0.029B 0.00
KemPharm (KMPH) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.020B 0.00
Cyanotech (CYAN) United States $0.019B 31.90
HANCOCK JAFFE (HJLI) United States $0.019B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.018B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.017B 0.00
RXi Pharmaceuticals (PHIO) United States $0.017B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
JanOne (JAN) United States $0.010B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00